Ace2 activation for treatment of heart, lung and kidney...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 38/48 (2006.01) C12N 9/48 (2006.01) C12N 9/64 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2489873

The invention relates to ACE2 activating compounds for prevention and treatment of cardiovascular disease, kidney disease, lung disease and hypertension. The invention also includes methods of diagnosing cardiovascular disease, kidney disease, lung disease and hypertension by measuring ACE2 expression or nucleotide polymorphism analysis.

L'invention porte sur des composés d'activation de ACE2 pour la prévention et le traitement de maladies cardio-vasculaires, de maladies rénales, de maladies pulmonaires et de l'hypertension. L'invention concerne aussi des procédés de diagnostic de maladies cardio-vasculaires, de maladies rénales, de maladies pulmonaires et de l'hypertension par la mesure de l'expression de ACE2 ou l'analyse de polymorphismes nucléotidiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ace2 activation for treatment of heart, lung and kidney... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ace2 activation for treatment of heart, lung and kidney..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ace2 activation for treatment of heart, lung and kidney... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1551196

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.